Evidence map›Paper›PMID 37605840›Full record

ArticleArthritis care & research2024

Incidence Rate and Factors Associated With Fractures Among Medicare Beneficiaries With Ankylosing Spondylitis in the United States.

Rachael Stovall, Emma Kersey, Jing Li, Rahaf Baker, Christine Anastasiou, Andriko Palmowski, Gabriela Schmajuk, Lianne Gensler, Jinoos Yazdany

Open access · bronzeAbstract read
In one paragraph

Article in Arthritis care & research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Prevalence and relative risk of fractures and osteoporosis in patients with ankylosing spondylitis: a systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Rachael StovallUniversity of California, San Francisco.ORCID 0000-0002-0355-4020
Emma KerseyUniversity of California, San Francisco.
Jing LiUniversity of California, San Francisco.ORCID 0000-0002-3298-2112
Rahaf BakerAlameda Health System, Oakland, California.
Christine AnastasiouUniversity of California, San Francisco.
Andriko PalmowskiUniversity of California, San Francisco, Charité - Universitätsmedizin Berlin, Berlin, Germany, and the Parker Institute, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-3456-0597
Gabriela SchmajukUniversity of California, San Francisco, and San Francisco Department of Veterans Affairs Healthcare System, San Francisco, California.ORCID 0000-0003-2687-5043
Lianne GenslerUniversity of California, San Francisco.ORCID 0000-0001-6314-5336
Jinoos YazdanyUniversity of California, San Francisco.ORCID 0000-0002-3508-4094
University of California, San Francisco · USAlameda Health System · USSan Francisco VA Medical Center · USUniversity of Copenhagen · DK

Funding

NRSA Training CoreTL1TR001871 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANAYA, ALKA M., SOMSOUK, MA · 2016 to 2025
$10.1M
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGYP30AR070155 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mary C Nakamura · 2016 to 2026
$8.2M
Skeletal Biology and Biomechanics (SBB) CoreP30AR075055 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Wenhan Chang · 2019 to 2026
$7.1M
Advancing Safety Process Innovation in Rheumatology (ASPIRE)R01HS028024 · AHRQ · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAZDANY, JINOOS · 2022 to 2025
$1.6M
Advancing Quality and Outcomes Measurement in RheumatologyK24AR074534 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jinoos Yazdany · 2019 to 2026
$1.5M
AHRQ HHS R01 HS028024NCATS NIH HHS TL1 TR001871NIAMS NIH HHS K24 AR074534NIAMS NIH HHS L30 AR081622NIAMS NIH HHS P30 AR070155NIAMS NIH HHS P30 AR075055NIAMS NIH HHS P30AR075055
6 · The paper itself

Abstract

objectiveWe evaluated the incidence rate and factors associated with fractures among adults with ankylosing spondylitis (AS).

methodsWe performed a retrospective cohort study with data from the Rheumatology Informatics System for Effectiveness registry linked to Medicare claims from 2016 to 2018. Patients were required to have two AS International Classification of Diseases codes 30 or more days apart and a subsequent Medicare claim. Then, 1 year of baseline characteristics were included, after which patients were observed for fractures. First, we calculated the incidence rate of fractures. Second, we constructed logistic regression models to identify factors associated with the fracture, including age, sex, race and ethnicity, body mass index, Medicare/Medicaid dual eligibility, area deprivation index, Charlson comorbidity index, smoking status, osteoporosis, historical fracture, and use of osteoporosis treatment, glucocorticoids, and opioids.

resultsWe identified 1,426 adults with prevalent AS. Mean ± SD age was 69.4 ± 9.8 years, 44.3% were female, and 77.3% were non-Hispanic White. Fractures occurred in 197 adults with AS. The overall incidence rate of fractures was 76.7 (95% confidence interval [CI] 66.4-88.6) per 1,000 person-years. Older age (odds ratio [OR] 2.8, 95% CI 1.39-5.65), historical fracture (OR 5.24, 95% CI 3.44-7.99), and use of more than 30 mg morphine equivalent (OR 1.86, 95% CI 1.08-3.19) conferred increased odds of fracture.

conclusionsIn this large sample of Medicare beneficiaries with AS, increasing age, historical fracture, and use of opioids had higher odds of fracture. Men and women were equally likely to have a fracture. Because opioid use was associated with fracture in AS, this high-risk population should be considered for interventions to mitigate risk.

Indexed as

Fractures, BoneOsteoporosisSpondylitis, AnkylosingAdultAgedFemaleHumansIncidenceMaleMedicareMiddle AgedRetrospective StudiesUnited States

Identifiers

PMID37605840
PMCPMC10843294
OpenAlexW4386046362

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.